discussed above, ciprofloxacin has vari¬ able activity against M pneumoniae and is not recommended for this organ¬ ism. The poor anaerobic coverage ofcip¬.
Ciprofloxacin . Clindamycin OR. Page 3. Aztreonam . Clindamycin. If concern for MRSA, use vancomycin instead of clindamycin and add anaerobic coverage with.
1. Ciprofloxacin (PO and IV) Spectrum: best gram negative coverage of FQs, but virtually no gram positive coverage. Lacks good anaerobic coverage. 2.
Moxifloxacinhas some anaerobic coverage while levofloxacin and ciprofloxacin do not. Metronidazole – no longer the 1st choice for C.diff
Ciprofloxacin. No activity in vitro vs. B. fragilis. Clindamycin. This Usually unnecessary to offer empiric double-coverage for anaerobic
Ciprofloxacin (PO and IV) Lacks good anaerobic coverage. Used for: many purposes including UTIs, double coverage of Pseudomonas including for HAP/HCAP/VAP
Guidelines for intra-abdominal and gynecological infections recommend anaerobic coverage with a single agent. Adding metronidazole for anaerobic coverage to
Moxifloxacinhas some anaerobic coverage while levofloxacin and ciprofloxacin do not. Metronidazole – no longer the 1st choice for C.diff
1. Ciprofloxacin (PO and IV) Spectrum: best gram negative coverage of FQs, but virtually no gram positive coverage. Lacks good anaerobic coverage. 2.
Comments